Thursday, March 23, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense Headlines – November 2, 2014

by Global Biodefense Staff
November 2, 2014

Troops to be checked for chemical exposure in Iraq | Aerosolized fungal infection from bats | Recommendations regarding Ebola response | EVD-68 cases fading, but more unexplained neuro illnesses | Evaluation of border entry screening for infectious diseases in humans | FDA approves vaccine for a rare meningitis | Ebola: Failures of imagination | The decision to publish an avian H7N1 gain-of-function experiment | Novel biosensor could allow rapid detection of Ebola virus | BARDA: The venture capital firm buried in the U.S. government | Drug that lost high-stakes political fight for funding now being used against Ebola | Better staffing seen as crucial to Ebola treatment in Africa | Light frequencies help sniff out deadly materials from a distance | Ebola genome browser now online to aid researchers | The bad, the worse and the over-interpreted | CSL-Novartis deal includes US cell-based flu vaccine plant | Joint Chiefs chairman urges 21-day quarantine for troops in Ebola zone | “Airborne” Ebola: A review of the issue | Mandatory Ebola quarantine is about politics, not public health | WHO updates Ebola PPE guidance for health providers | Army providing communications backbone for Ebola response

See what we’re reading this week at Global Biodefense on EVD-68, DoD communication networks for Ebola crisis regions, new meningitis vaccine and more…

Troops to be checked for chemical exposure in Iraq (NY Times)

Aerosolized fungal infection from bats (GMU Pandora Report)

EVD-68 cases fading, but more unexplained neuro illnesses (CIDRAP)

Evaluation of border entry screening for infectious diseases in humans (EID Journal)

FDA approves vaccine for a rare meningitis (NY Times)

Ebola: Failures of imagination (Lanard and Sandman)

The decision to publish an avian H7N1 gain-of-function experiment (mBio)

Novel biosensor could allow rapid detection of Ebola virus (UC Santa Cruz)

BARDA: The venture capital firm buried in the U.S. government (Marketplace)

Drug that lost high-stakes political fight for funding now being used against Ebola (HP)

Better staffing seen as crucial to Ebola treatment in Africa (NY Times)

Light frequencies help sniff out deadly materials from a distance (HSNW)

Ebola genome browser now online to aid researchers (HealthCanal)

The bad, the worse and the over-interpreted (Virology Down Under)

CSL-Novartis deal includes US cell-based flu vaccine plant (CIDRAP)

Joint Chiefs chairman urges 21-day quarantine for troops in Ebola zone (NY Times)

Mandatory Ebola quarantine is about politics, not public health (The Conversation)

WHO updates Ebola PPE guidance for health providers (CIDRAP)

Army providing communications backbone for Ebola response (Defense Systems)

Related Posts

Biodefense Headlines – 12 March 2023
News Scan

Biodefense Headlines – 12 March 2023

March 12, 2023
Biodefense Headlines – 24 January 2023
News Scan

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023
News Scan

Biodefense Headlines – 17 January 2023

January 17, 2023
Biodefense Headlines – 10 January 2023
News Scan

Biodefense Headlines – 10 January 2023

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC